Your browser doesn't support javascript.
loading
Comprehensive epithelial tubo-ovarian cancer risk prediction model incorporating genetic and epidemiological risk factors.
Lee, Andrew; Yang, Xin; Tyrer, Jonathan; Gentry-Maharaj, Aleksandra; Ryan, Andy; Mavaddat, Nasim; Cunningham, Alex P; Carver, Tim; Archer, Stephanie; Leslie, Goska; Kalsi, Jatinder; Gaba, Faiza; Manchanda, Ranjit; Gayther, Simon; Ramus, Susan J; Walter, Fiona M; Tischkowitz, Marc; Jacobs, Ian; Menon, Usha; Easton, Douglas F; Pharoah, Paul; Antoniou, Antonis C.
Affiliation
  • Lee A; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Yang X; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Tyrer J; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
  • Gentry-Maharaj A; MRC Clinical Trials Unit, Institute of Clinical Trials & Methodology, University College London, London, UK.
  • Ryan A; MRC Clinical Trials Unit, Institute of Clinical Trials & Methodology, University College London, London, UK.
  • Mavaddat N; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Cunningham AP; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Carver T; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Archer S; The Primary Care Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Leslie G; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Kalsi J; Department of Women's Cancer, University College London Institute for Women's Health, London, UK.
  • Gaba F; Department of Epidemiology and Public Health, University College London Research, London, UK.
  • Manchanda R; CRUK Barts Cancer Centre, Wolfson Institute of Preventive Medicine, London, UK.
  • Gayther S; CRUK Barts Cancer Centre, Wolfson Institute of Preventive Medicine, London, UK.
  • Ramus SJ; Department of Gynaecological Oncology, Barts Health NHS Trust, London, UK.
  • Walter FM; Department of Health Services Research, London School of Hygiene & Tropical Medicine, London, UK.
  • Tischkowitz M; Center for Bioinformatics and Functional Genomics, Cedars-Sinai Medical Center Samuel Oschin Comprehensive Cancer Institute, Los Angeles, California, USA.
  • Jacobs I; University of New South Wales, School of Women's and Children's Health, Randwick, New South Wales, Australia.
  • Menon U; Adult Cancer Program, Lowy Cancer Research Centre, University of New South Wales, Sydney, New South Wales, Australia.
  • Easton DF; The Primary Care Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Pharoah P; Department of Medical Genetics, NIHR Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, UK.
  • Antoniou AC; Department of Women's Cancer, University College London Institute for Women's Health, London, UK.
J Med Genet ; 59(7): 632-643, 2022 07.
Article in En | MEDLINE | ID: mdl-34844974

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Breast Neoplasms Type of study: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Female / Humans Language: En Journal: J Med Genet Year: 2022 Type: Article Affiliation country: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Breast Neoplasms Type of study: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Female / Humans Language: En Journal: J Med Genet Year: 2022 Type: Article Affiliation country: United kingdom